you are here:

Dr Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE089A01023 | SECTOR: Pharmaceuticals

BSE Live

Apr 20, 16:00
5153.95 183.40 (3.69%)
Volume
AVERAGE VOLUME
5-Day
127,409
10-Day
96,925
30-Day
57,010
229,068
  • Prev. Close

    4970.55

  • Open Price

    5100.00

  • Bid Price (Qty.)

    5105.00 (2)

  • Offer Price (Qty.)

    5150.00 (30)

NSE Live

Apr 20, 15:59
5156.75 188.65 (3.80%)
Volume
AVERAGE VOLUME
5-Day
2,370,214
10-Day
1,924,352
30-Day
1,213,181
3,484,976
  • Prev. Close

    4968.10

  • Open Price

    5100.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    5156.75 (1524)

Financials

2020 2019 2018 2017 2016
Yearly Results of Dr Reddys Laboratories (in Rs. Cr.) Mar '20 Mar '19 Mar '18 Mar '17 Mar '16  
Net Sales/Income from operations 11,803.00 10,466.70 9,302.60 9,628.10 10,234.80  
Other Operating Income 47.40 158.80 56.70 91.70 57.10  
Total Income From Operations 11,850.40 10,625.50 9,359.30 9,719.80 10,291.90  
EXPENDITURE  
Consumption of Raw Materials 2,556.50 2,103.20 2,011.00 1,817.60 2,072.70  
Purchase of Traded Goods 1,117.20 868.60 671.60 671.50 610.40  
Increase/Decrease in Stocks -99.90 66.00 -51.60 1.90 -28.80  
Power & Fuel -- -- -- -- --  
Employees Cost 2,030.20 1,931.90 1,843.00 1,803.30 1,693.40  
Depreciation 789.20 780.60 774.10 735.10 927.50  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- 998.50 649.50  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 3,376.80 3,356.10 3,555.40 2,681.40 2,951.40  
P/L Before Other Inc. , Int., Excpt. Items & Tax 2,080.40 1,519.10 555.80 1,010.50 1,415.80  
Other Income 743.20 238.40 204.00 591.20 324.90  
P/L Before Int., Excpt. Items & Tax 2,823.60 1,757.50 759.80 1,601.70 1,740.70  
Interest 47.80 56.80 62.80 57.20 64.10  
P/L Before Exceptional Items & Tax 2,775.80 1,700.70 697.00 1,544.50 1,676.60  
Exceptional Items -- -- -- -- --  
P/L Before Tax 2,775.80 1,700.70 697.00 1,544.50 1,676.60  
Tax -161.90 423.40 130.10 160.40 302.30  
P/L After Tax from Ordinary Activities 2,937.70 1,277.30 566.90 1,384.10 1,374.30  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 2,937.70 1,277.30 566.90 1,384.10 1,374.30  
Equity Share Capital 83.10 83.00 83.00 82.90 85.30  
Reserves Excluding Revaluation Reserves 15,108.80 12,601.10 11,724.80 11,517.70 11,520.10  
Equity Dividend Rate (%) 500.00 400.00 400.00 400.00 400.00  
EPS Before Extra Ordinary  
Basic EPS 177.23 76.98 34.19 83.05 80.59  
Diluted EPS 176.88 76.85 34.12 82.88 80.34  
EPS After Extra Ordinary  
Basic EPS. 177.23 76.98 34.19 83.05 80.59  
Diluted EPS. 176.88 76.85 34.12 82.88 80.34  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited

Results of Dr Reddys Labs